AJRCCM -- Table of Contents (March 15 2003, 167 [6])

EDITORIALS:

Robert M. Jasmer and Charles L. Daley: Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection: Is It Safe?; Am. J. Respir. Crit. Care Med. 2003; 167: 809-810 [Full Text] [PDF]

David E. Griffith: Emergence of Nontuberculous Mycobacteria as Pathogens in Cystic Fibrosis; Am. J. Respir. Crit. Care Med. 2003; 167: 810-812 [Full Text] [PDF]

CLINICAL COMMENTARY:

Kelvin H.-V. Tan, Michael Mulheran, Alan J. Knox, and Alan R. Smyth: Aminoglycoside Prescribing and Surveillance in Cystic Fibrosis; Am. J. Respir. Crit. Care Med. 2003; 167: 819-823 [Full Text] [PDF]

PULMONARY PERSPECTIVE:

Peter J. Barnes: Theophylline: New Perspectives for an Old Drug; Am. J. Respir. Crit. Care Med. 2003; 167: 813-818 [Full Text] [PDF]

ARTICLES:

A. Tuberculosis Mycobacteria and Cystic Fibrosis:

Jason E. Stout, John J. Engemann, Allen C. Cheng, Ellen R. Fortenberry, and Carol D. Hamilton: Safety of 2 Months of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis; Am. J. Respir. Crit. Care Med. 2003; 167: 824-827. First published online November 21 2002 as doi:10.1164/rccm.200209-998OC [Abstract] [Full Text] [PDF]

Kenneth N. Olivier, David J. Weber, Richard J. Wallace, Jr., Ali R. Faiz, Ji-Hyun Lee, Yansheng Zhang, Barbara A. Brown-Elliot, Allison Handler, Rebecca W. Wilson, Michael S. Schechter, Lloyd J. Edwards, Subha Chakraborti, and Michael R. Knowles: Nontuberculous Mycobacteria: I: Multicenter Prevalence Study in Cystic Fibrosis; Am. J. Respir. Crit. Care Med. 2003; 167: 828-834. First published online November 14 2002 as doi:10.1164/rccm.200207-678OC [Abstract] [Full Text] [PDF]

Kenneth N. Olivier, David J. Weber, Ji-Hyun Lee, Allison Handler, Gail Tudor, Paul L. Molina, Joseph Tomashefski, and Michael R. Knowles: Nontuberculous Mycobacteria: II: Nested-Cohort Study of Impact on Cystic Fibrosis Lung Disease; Am. J. Respir. Crit. Care Med. 2003; 167: 835-840. First published online November 14 2002 as doi:10.1164/rccm.200207-679OC [Abstract] [Full Text] [PDF]

B. Cystic Fibrosis:

Ronald L. Gibson, Julia Emerson, Sharon McNamara, Jane L. Burns, Margaret Rosenfeld, Ann Yunker, Nicole Hamblett, Frank Accurso, Mark Dovey, Peter Hiatt, Michael W. Konstan, Richard Moss, George Retsch-Bogart, Jeffrey Wagener, David Waltz, Robert Wilmott, Pamela L. Zeitlin, and Bonnie Ramsey: Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis; Am. J. Respir. Crit. Care Med. 2003; 167: 841-849. First published online December 12 2002 as doi:10.1164/rccm.200208-855OC [Abstract] [Full Text] [PDF] [Online Supplement]

C. Exhaled Breath Condensates:

Géza Vass, Éva Huszár, Erzsébet Barát, Márta Valyon, Domonkos Kiss, István Pénzes, Mónika Augusztinovicz, and Ildikó Horváth: Comparison of Nasal and Oral Inhalation during Exhaled Breath Condensate Collection; Am. J. Respir. Crit. Care Med. 2003; 167: 850-855. First published online December 18 2002 as doi:10.1164/rccm.200207-716BC [Abstract] [Full Text] [PDF] [Online Supplement]

D. Nitric Oxide and Airway Epithelium:

Itsuro Jibiki, Shu Hashimoto, Shuichiro Maruoka, Yasuhiro Gon, Atsushi Matsuzawa, Hideki Nishitoh, Hidenori Ichijo, and Takashi Horie: Apoptosis Signal-Regulating Kinase 1–Mediated Signaling Pathway Regulates Nitric Oxide–Induced Activator Protein-1 Activation in Human Bronchial Epithelial Cells; Am. J. Respir. Crit. Care Med. 2003; 167: 856-861 [Abstract] [Full Text] [PDF]

E. Nose at High Altitude:

Heimo Mairbäurl, Jörn Weymann, Andreas Möhrlein, Erik R. Swenson, Marco Maggiorini, J. Simon R. Gibbs, and Peter Bärtsch: Nasal Epithelium Potential Difference at High Altitude (4,559 m): Evidence for Secretion; Am. J. Respir. Crit. Care Med. 2003; 167: 862-867. First published online January 9 2003 as doi:10.1164/rccm.200208-864OC [Abstract] [Full Text] [PDF]

F. Sepsis:

Yoshihisa Morita, Ian Chin-Yee, Pei Yu, William J. Sibbald, and Claudio M. Martin: Critical Oxygen Delivery in Conscious Septic Rats under Stagnant or Anemic Hypoxia; Am. J. Respir. Crit. Care Med. 2003; 167: 868-872. First published online December 12 2002 as doi:10.1164/rccm.200205-490OC [Abstract] [Full Text] [PDF]

G. Chronic Obstructive Pulmonary Disease:

Florence Ribera, Benoit N'Guessan, Joffrey Zoll, Dominique Fortin, Bernard Serrurier, Bertrand Mettauer, Xavier Bigard, Renée Ventura-Clapier, and Eliane Lampert: Mitochondrial Electron Transport Chain Function Is Enhanced in Inspiratory Muscles of Patients with Chronic Obstructive Pulmonary Disease; Am. J. Respir. Crit. Care Med. 2003; 167: 873-879. First published online December 18 2002 as doi:10.1164/rccm.200206-519OC [Abstract] [Full Text] [PDF]

Andrew L. Ries, Robert M. Kaplan, Roseann Myers, and Lela M. Prewitt: Maintenance after Pulmonary Rehabilitation in Chronic Lung Disease: A Randomized Trial; Am. J. Respir. Crit. Care Med. 2003; 167: 880-888. First published online December 27 2002 as doi:10.1164/rccm.200204-318OC [Abstract] [Full Text] [PDF] [Online Supplement]

H. Pulmonary Veno-occlusive Disease:

James R. Runo, Cindy L. Vnencak-Jones, Melissa Prince, James E. Loyd, Lisa Wheeler, Ivan M. Robbins, Kirk B. Lane, John H. Newman, Joyce Johnson, William C. Nichols, and John A. Phillips, III: Pulmonary Veno-occlusive Disease Caused by an Inherited Mutation in Bone Morphogenetic Protein Receptor II; Am. J. Respir. Crit. Care Med. 2003; 167: 889-894. First published online November 21 2002 as doi:10.1164/rccm.200208-861OC [Abstract] [Full Text] [PDF]

I. Nitric Oxide and Heart Failure:

Shunsuke Natori, Naoyuki Hasebe, Yin-Tie Jin, Tomoyuki Matsusaka, Akira Ido, Hironobu Matsuhashi, Tadashi Ihara, and Kenjiro Kikuchi: Inhaled Nitric Oxide Modifies Left Ventricular Diastolic Stress in the Presence of Vasoactive Agents in Heart Failure; Am. J. Respir. Crit. Care Med. 2003; 167: 895-901. First published online January 6 2003 as doi:10.1164/rccm.200201-057OC [Abstract] [Full Text] [PDF]

J. Sleep Apnea and Heart-Rate Variability:

Lucia Spicuzza, Luciano Bernardi, Alessandro Calciati, and Giuseppe Ugo Di Maria: Autonomic Modulation of Heart Rate during Obstructive versus Central Apneas in Patients with Sleep-disordered Breathing; Am. J. Respir. Crit. Care Med. 2003; 167: 902-910. First published online December 27 2002 as doi:10.1164/rccm.200201-006OC [Abstract] [Full Text] [PDF] [Online Supplement]

K. Diabetes and Lung Function:

Robert E. Walter, Alexa Beiser, Rachel J. Givelber, George T. O'Connor, and Daniel J. Gottlieb: Association between Glycemic State and Lung Function: The Framingham Heart Study; Am. J. Respir. Crit. Care Med. 2003; 167: 911-916 [Abstract] [Full Text] [PDF]

L. In Utero Smoke Exposure:

Frank D. Gilliland, Kiros Berhane, Yu-Fen Li, Edward B. Rappaport, and John M. Peters: Effects of Early Onset Asthma and In Utero Exposure to Maternal Smoking on Childhood Lung Function; Am. J. Respir. Crit. Care Med. 2003; 167: 917-924. First published online December 12 2002 as doi:10.1164/rccm.200206-616OC [Abstract] [Full Text] [PDF]

M. Bleomycin-induced Fibrosis:

Annie Pardo, Víctor Ruiz, José Luis Arreola, Remedios Ramírez, José Cisneros-Lira, Miguel Gaxiola, Roberto Barrios, Subbarao V. Kala, Michael W. Lieberman, and Moisés Selman: Bleomycin-induced Pulmonary Fibrosis Is Attenuated in ${gamma}$ -Glutamyl Transpeptidase–Deficient Mice; Am. J. Respir. Crit. Care Med. 2003; 167: 925-932. First published online December 4 2002 as doi:10.1164/rccm.200209-1007OC [Abstract] [Full Text] [PDF] [Online Supplement]

CORRESPONDENCE:

Laurence C. Carmichael, Thomas L. Petty, Peter Q. Eichacker, Steven M. Banks, Charles Natanson, Tihomir Stefanec, Peter Q. Eichacker, Steven M. Banks, Charles Natanson, Nicola Petrucci, Steven M. Banks, Charles Natanson, and Peter Q. Eichacker: Tidal volumes in ards and meta-analysis; Am. J. Respir. Crit. Care Med. 2003; 167: 933-936 [Full Text] [PDF]

Isa Cerveri, Angelo Corsico, Maria C. Zoia, Jørgen Vestbo, and Peter Lange: Gold Stage 0; Am. J. Respir. Crit. Care Med. 2003; 167: 936 [Full Text] [PDF]